Aurium变色人工晶状体植入术后对比敏感度和眩光对比敏感度的研究

目的 研究Aurium变色人工晶状体对术后对比敏感度和眩光对比敏感度的影响.方法 临床病例系列对比研究.选取2010年8月至2011年4月在南昌大学第二附属医院眼科就诊的白内障超声乳化联合人工晶状体植入术后患者,且随访资料完整的病例70例(眼),其中37例为Aurium (model400)变色人工晶状体组,33例为黄色蓝光滤过型IQ (SN60WF)人工晶状体组.观察患者术后3个月时的裸眼视力(UCVA),最佳矫正视力(BCVA),对比敏感度(CS)和眩光对比敏感度(GS).结果 二组患者术后3个月时的裸眼视力和最佳矫正视力差异均无统计学意义(P＞0.05).Aurium组和IQ组在明适应、明适应眩光、暗适应条件下,两组之间的对比敏感度和眩光对比敏感度差异无统计学意义(P＞0.05),在暗适应眩光条件下Aurium组的眩光对比敏感度(空间频率3 cpd、6 cpd)要优于黄色蓝光滤过型IQ组,差异有统计学意义(P＜0.05).结论 植入Aurium变色人工晶状体术后患者的视力与黄色蓝光滤过型IQ人工晶状体的视力差异无统计学意义.Aurium变色人工晶状体在暗适应眩光条件下,空间频率(3 cpd、6 cpd)的眩光对比敏感度要优于黄色蓝光滤过型IQ人工晶状体.     

非球面人工晶状体植入术后视觉质量评价

目的 评价非球面设计的人工晶状体AcrySof(R) IQ对提高老年性白内障患者术后视功能的作用.方法 采用同期临床对照研究,超声乳化白内障吸出联合人工晶状体植入术后的老年性白内障患者132例(160眼),其中植入AcrySof(R) IQ IOL 60例76眼,为IQ组;植入AcrySof(R) Natural 72例84眼,为Natural 组.观察患者的术后视力、对比敏感度和眩光敏感度、球差和并发症,问卷调查患者不良视觉症状和满意度.结果 术后3个月,IQ组裸眼视力(uncorrected visual acuity,UCVA)为4.92±0.10,最佳矫正视力(best corrected visual acuity,BCVA)为5.02±0.10; Natural组UCVA为4.89±0.12, BCVA为5.00±0.09;差异均无统计学意义(P＞0.05).低、中、高各频段对比敏感度和眩光敏感度 IQ组为47.44±10.95、27.72±6.69、7.62±2.04和40.61±10.48、22.73±6.88、6.38±1.22;Natural组为31.55±6.68、24.67±5.49、6.17±1.43、27.27±5.78、17.62±3.90、4.83±0.82,差异有统计学意义(P＜0.01).球差IQ组为(0.09±0.04)μm,Natural组为(0.52±0.17)μm,差异有统计学意义(t=22.15,P=0.000).问卷结果 显示IQ组较Natural组术后眩光、光晕的发生率低,患者满意度高.结论 非球面人工晶状体AcrySof(R)IQ在一定程度上平衡了角膜的正球差,减少了人工晶状体眼的球差,提高了对比敏感度和眩光敏感度,改善了视觉质量,获得了患者满意的效果.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

Strabisme Alternant - Etude clinique - traitement

The author defines motor and sensory alternation: the term alternation should not be used in isolation, it should always be accompanied by the name of the parameter concerned. Sensory alternation is always found together with motor alternation but the reverse is not true.The examining criteria for a diagnosis of sensory alternation are given, sensory alternation must not be confused with alternating inhibition. Working from clinical observations of cases of motor alternating strabismus, the author selects 2 types of binocular sensory relations which allow one to differentiate between:- cases of primary alternating strabismus- cases of secondary alternating strabismusThese forms will develop in different ways; in both cases a cure is possible providing that the right treatment is prescribed and once prescribed carefully followed, etc. It is always a case of serious forms of strabismus whose developmental period is spread over several years.According to the authors, the frequency of cases of true primary strabismus is from 1–3%, the frequency of cases of secondary alternating strabismus varies according to the type of therapy practised on cases of monocular strabismus with amblyopia. These latter will become cases of alternating strabismus under the influence of certain types of therapy carried out over several years (penalization, rocking, alternated occlusion, etc...).Experimental data on kittens confirm clinical data; kittens placed in abnormal environments during the sensitive period will show modification in the distribution of cortical cells and the absence of binocular cells (either because the excitation of the two eyes was not simultaneous, or not identical: artificial strabismus, occlusion, opaque glasses). This disturbances become irreversible after a certain period of exposure (a function of age, length of exposure, etc...).It is thus necessary to bear in mind: 1) the iatrogenic risks of certain orthoptic treatments, 2) the necessity for a binocular form of treatment as soon as possible, as once a certain stage is passed, cortical plasticity diminishes and the elaboration of normal binocular relations becomes impossible.

---

     

Effects of Adenosine Agonists on Intraocular Pressure and Aqueous Humor Dynamics in Cynomolgus Monkeys

The effects of single or multiple topical doses of the relatively selective A₁adenosine receptor agonists (R)-phenylisopropyladenosine (R-PIA) and N⁶-cyclohexyladenosine (CHA) on intraocular pressure (IOP), aqueous humor flow (AHF) and outflow facility were investigated in ocular normotensive cynomolgus monkeys. IOP and AHF were determined, under ketamine anesthesia, by Goldmann applanation tonometry and fluorophotometry, respectively. Total outflow facility was determined by anterior chamber perfusion under pentobarbital anesthesia. A single unilateral topical application of R-PIA (20–250 μg) or CHA (20–500 μg) produced ocular hypertension (maximum rise=4.9 or 3.5 mmHg) within 30 min, followed by ocular hypotension (maximum fall=2.1 or 3.6 mmHg) from 2–6 hr. The relatively selective adenosine A₂antagonist 3,7-dimethyl-1-propargylxanthine (DMPX, 320 μg) inhibited the early hypertension, without influencing the hypotension. Neither 100 μg R-PIA nor 500 μg CHA clearly altered AHF. Total outflow facility was increased by 71% 3 hr after 100 μg R-PIA. In conclusion, the early ocular hypertension produced by topical adenosine agonists in cynomolgus monkeys is associated with the activation of adenosine A₂receptors, while the subsequent hypotension appears to be mediated by adenosine A₁receptors and results primarily from increased outflow facility.